chr1-203496118-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014359.4(OPTC):c.113G>T(p.Gly38Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000713 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014359.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OPTC | NM_014359.4 | c.113G>T | p.Gly38Val | missense_variant | 2/8 | ENST00000367222.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OPTC | ENST00000367222.7 | c.113G>T | p.Gly38Val | missense_variant | 2/8 | 1 | NM_014359.4 | P1 | |
OPTC | ENST00000448911.1 | c.113G>T | p.Gly38Val | missense_variant | 1/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251398Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135884
GnomAD4 exome AF: 0.0000711 AC: 104AN: 1461836Hom.: 0 Cov.: 32 AF XY: 0.0000660 AC XY: 48AN XY: 727212
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2023 | The c.113G>T (p.G38V) alteration is located in exon 2 (coding exon 1) of the OPTC gene. This alteration results from a G to T substitution at nucleotide position 113, causing the glycine (G) at amino acid position 38 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at